大葉大學圖書館 |

Gene- and cell-based treatment strategies for the eye[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	617.706
書名/作者:	Gene- and cell-based treatment strategies for the eye/ edited by Elizabeth P. Rakoczy.
其他作者:	Rakoczy, Elizabeth P.
出版者:	Berlin, Heidelberg : : Springer Berlin Heidelberg :, 2015.
面頁冊數:	vii, 95 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Eye - Diseases
標題:	Medicine & Public Health.
標題:	Ophthalmology.
標題:	Human Genetics.
ISBN:	9783662451885 (electronic bk.)
ISBN:	9783662451878 (paper)
內容註:	Introduction -- Gene Therapy for Leber's Congenital Amaurosis due to RPE65 Mutations -- Gene Therapy for Choroideremia -- Gene Therapy for Dominantly Inherited Retinal Degeneration -- Age-Related Macular Degeneration: The Challenges -- Neovascular Age Related Macular Degeneration: Secretion Gene Therapy -- Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium for the Treatment of Macular Degeneration -- Restoring Physiologic Barriers Against Neovascular Invasion.
摘要、提要註:	In this book, leading experts provide detailed descriptions of the exciting treatments that are expected to become part of the ophthalmologist’s arsenal within the next 10–20 years. The treatments discussed relate to a wide variety of conditions, including macular degeneration, Leber’s congenital amaurosis, retinitis pigmentosa and choroideremia. The authors explain clearly how different gene and cell therapies work and provide first-hand accounts of the difficulties that they have faced in bringing these technologies to clinical trial, such as issues relating to funding and ownership. Results achieved to date are presented, and the further steps required before the treatment in question can become a routine option are considered. Gene- and Cell-Based Treatment Strategies for the Eye is unique in showing the organic development of cutting-edge science into potential treatments for eye disease without compromising on accurate reporting of scientific facts. It will persuade the average practitioner or researcher – whether ophthalmologist, health worker, or scientist – that change is indeed coming and is not just a hollow promise of the tabloid media.
電子資源:	http://dx.doi.org/10.1007/978-3-662-45188-5

Gene- and cell-based treatment strategies for the eye[electronic resource] /
Gene- and cell-based treatment strategies for the eye[electronic resource] /edited by Elizabeth P. Rakoczy. - Berlin, Heidelberg :Springer Berlin Heidelberg :2015. - vii, 95 p. :ill. (some col.), digital ;24 cm. - Essentials in ophthalmology,1612-3212. - Essentials in ophthalmology..

Introduction -- Gene Therapy for Leber's Congenital Amaurosis due to RPE65 Mutations -- Gene Therapy for Choroideremia -- Gene Therapy for Dominantly Inherited Retinal Degeneration -- Age-Related Macular Degeneration: The Challenges -- Neovascular Age Related Macular Degeneration: Secretion Gene Therapy -- Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium for the Treatment of Macular Degeneration -- Restoring Physiologic Barriers Against Neovascular Invasion.

In this book, leading experts provide detailed descriptions of the exciting treatments that are expected to become part of the ophthalmologist’s arsenal within the next 10–20 years. The treatments discussed relate to a wide variety of conditions, including macular degeneration, Leber’s congenital amaurosis, retinitis pigmentosa and choroideremia. The authors explain clearly how different gene and cell therapies work and provide first-hand accounts of the difficulties that they have faced in bringing these technologies to clinical trial, such as issues relating to funding and ownership. Results achieved to date are presented, and the further steps required before the treatment in question can become a routine option are considered. Gene- and Cell-Based Treatment Strategies for the Eye is unique in showing the organic development of cutting-edge science into potential treatments for eye disease without compromising on accurate reporting of scientific facts. It will persuade the average practitioner or researcher – whether ophthalmologist, health worker, or scientist – that change is indeed coming and is not just a hollow promise of the tabloid media.

ISBN: 9783662451885 (electronic bk.)

Standard No.: 10.1007/978-3-662-45188-5doiSubjects--Topical Terms:

606536
Eye
--Diseases

LC Class. No.: RE46

Dewey Class. No.: 617.706

Gene- and cell-based treatment strategies for the eye[electronic resource] /
LDR:02673nam a2200325 a 4500 001 426471
003 DE-He213
005 20150907113511.0
006 m d
007 cr nn 008maaau
008 151119s2015 gw s 0 eng d
020 $a 9783662451885 (electronic bk.)
020 $a 9783662451878 (paper)
024 7 $a 10.1007/978-3-662-45188-5 $2 doi
035 $a 978-3-662-45188-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RE46
072 7 $a MJQ $2 bicssc
072 7 $a MED063000 $2 bisacsh
082 0 4 $a 617.706 $2 23
090 $a RE46 $b .G326 2015
245 0 0 $a Gene- and cell-based treatment strategies for the eye $h [electronic resource] / $c edited by Elizabeth P. Rakoczy.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2015.
300 $a vii, 95 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Essentials in ophthalmology, $x 1612-3212
505 0 $a Introduction -- Gene Therapy for Leber's Congenital Amaurosis due to RPE65 Mutations -- Gene Therapy for Choroideremia -- Gene Therapy for Dominantly Inherited Retinal Degeneration -- Age-Related Macular Degeneration: The Challenges -- Neovascular Age Related Macular Degeneration: Secretion Gene Therapy -- Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium for the Treatment of Macular Degeneration -- Restoring Physiologic Barriers Against Neovascular Invasion.
520 $a In this book, leading experts provide detailed descriptions of the exciting treatments that are expected to become part of the ophthalmologist’s arsenal within the next 10–20 years. The treatments discussed relate to a wide variety of conditions, including macular degeneration, Leber’s congenital amaurosis, retinitis pigmentosa and choroideremia. The authors explain clearly how different gene and cell therapies work and provide first-hand accounts of the difficulties that they have faced in bringing these technologies to clinical trial, such as issues relating to funding and ownership. Results achieved to date are presented, and the further steps required before the treatment in question can become a routine option are considered. Gene- and Cell-Based Treatment Strategies for the Eye is unique in showing the organic development of cutting-edge science into potential treatments for eye disease without compromising on accurate reporting of scientific facts. It will persuade the average practitioner or researcher – whether ophthalmologist, health worker, or scientist – that change is indeed coming and is not just a hollow promise of the tabloid media.
650 0 $a Eye $x Diseases $x Gene therapy. $3 606536
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Ophthalmology. $3 383342
650 2 4 $a Human Genetics. $3 464334
700 1 $a Rakoczy, Elizabeth P. $3 606534
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Essentials in ophthalmology. $3 606535
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-45188-5
950 $a Medicine (Springer-11650)